Chlamydia pneumoniae infection and atherosclerosis;Chlamydia pneumoniae und Atherosklerose

Deutsche Medizinische Wochenschrift

Volumn 122, Issue 36, 1997, Pages 1092-1095

  Marre, R ^a,b   Essig, A ^a,b  

^a UNIVERSITY OF ULM   (Germany)

^b Abt fü Med Mikrobiol Hyg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ATHEROSCLEROSIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; DRUG EFFICACY; HUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; SHORT SURVEY; ULTRASTRUCTURE;

EID: 0030762149     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1233727     Document Type: Short Survey

References (11)

1. Campbell, L. A., E. R. O'Brien, A. L. Cappuccio, C. C. Kuo, S. P. Wang, D. Stewart, D. L. Patton, P. K. Cummings, J. T. Grayston: Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J. Infect. Dis. 172 (1995), 585-588.
2. Gaydos, C. A., J. T. Summersgill, N. N. Sahney, J. A. Ramirez, T. C. Quinn: Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect. Immun. 64 (1996), 1614-1620.
3. Godzik, K. L., E. R. O'Brien, S. K. Wang, C. C. Kuo: In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J. Clin. Microbiol. 33 (1995), 2411-2414.
4. Heinemann, M., M. Susa, U. Simnacher, R. Marre, A. Essig: Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect. Immun. 64 (1996), 4872-4875.
5. Kuo, C. C., J. T. Grayston, L. A. Campbell, Y. A. Goo, R. W. Wissler, E. P. Benditt: Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Prac. nat. Acad. Sci. USA 92 (1995), 6911-6914.
6. Kuo, C. C., A. Shor, L. A. Campbel, H. Fukushi, D. L. Patton, J. T. Grayston: Demonstration of Chlamydia pneumoniae in atheroslerotic lesions of coronary arteries. J. Infect. Dis. 167 (1993), 841-849.
7. Ramirez, J. A.: Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atheroslerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann. intern. Med. 125 (1996), 979-982.
8. Saikku, P., M. Leinonen, L. Tenkanen, E. Linnanmaki, M. R. Ekman, V. Manninen, M. Manttari, M. H. Frick, J. K. Huttunen: Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann. intern. Med. 116 (1992), 273-278.
9. Thom, D. H., J. T. Grayston, D. S. Siscovick, S. P. Wang, N. S. Weiss, J. R. Daling: Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. J. Amer. Med. Ass. 268 (1992), 68-72.
10. Torzewski, J., D. E. Bowyer, J. Waltenberger, C. Fitzsimmons: Processes in atherogenesis: complement activation. zur Publikation akzeptiert in Atherosclerosis (1997).
11. Weiss, S. M., P. M. Roblin, C. A. Gaydos, P. Cummings, D. L. Patton, N. Schulhoff, J. Shani, R. Frankel, K. Penney, T. C. Quinn, M. R. Hammerschlag, J. Schachter: Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J. Infect. Dis. 173 (1996), 957-962.